LLOYD A ROWLAND
CIK 1236395 · General Counsel · last filed 2025-03-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$381.5K
Companies
3
Total Filings
51
Lifetime Open-Market Net
-$1.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTMX | General Counsel | 120,594 | $3.01 | $363.0K | $46.0K | 19 | 2025-03-20 |
| XNCR | Sr. V.P. and General Counsel | 1,501 | $12.33 | $18.5K | $0 | 5 | 2016-01-28 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | VP, Chief Compliance Officer | 39,091 | — | — | -$1.33M | 26 | 2012-07-26 |
Recent Filings · Page 6 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-01-04 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Mixed | +3,000 | -$31.1K | EDGAR |
Showing 51–51 of 51
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.